in vivo Studies Articles

Bio X Cell New Product Launch: RecombiMAb – Recombinant Antibodies

Recombinant antibodies for in vivo useWhat Are RecombiMAb™ Recombinant Antibodies? Bio X Cell RecombiMAb™ monoclonal antibodies are recombinant antibodies with the exact same antigen-binding variable domains as the traditional antibodies that they are derived...

Macrophages weaken TLR9 agonist antitumor activity through interacting with the anti-PD-1 antibody Fc domain

A combination of TLR9 agonists and an anti-PD-1 antibody has been reported effective in immunocompetent mice. However, the role of innate immunity has not yet been explained. In a recent article published by the Cancers, by using Bio X Cell’s anti-mouse PD-1 in vivo...

Scientists identified TRAPPC4 as a crucial PD-L1 regulator

Tumour cells escape T cell-mediated immunosurveillance through the interaction between programmed death (PD-1) ligand 1 (PD-L1) on tumour cells and PD-1 on T cells. Strategies disturbing PD-1/PD-L1 have shown clinical advantages in various cancers. However, the...

LincRNA EPIC1 Mediates Immunotherapy Resistance

Bio X Cell has recently released a blog post talking about the role of LincRNA EPIC1 in cancer immunology. Below are the highlights from the blog post:The ability of tumour cells to evade immune detection plays a critical role in tumour development. Although...

Macrophages weaken TLR9 agonist antitumor activity through interacting with the anti-PD-1 antibody Fc domain

Mar 23, 2022 | Cancer, Immunology, in vivo Studies

A combination of TLR9 agonists and an anti-PD-1 antibody has been reported effective in immunocompetent mice. However,...

Scientists identified TRAPPC4 as a crucial PD-L1 regulator

Feb 18, 2022 | Cancer, in vivo Studies

Tumour cells escape T cell-mediated immunosurveillance through the interaction between programmed death (PD-1) ligand...

LincRNA EPIC1 Mediates Immunotherapy Resistance

Dec 22, 2021 | Cancer, in vivo Studies

Bio X Cell has recently released a blog post talking about the role of LincRNA EPIC1 in cancer immunology. Below are...

Preventing Breast Cancer Metastasis: A Role for Cathepsin C Inhibitors

Nov 2, 2021 | Cancer, in vivo Studies

Bio X Cell has recently released a blog post talking about the role of cathepsin c inhibitors in cancer metastasis....

Bio X Cell New Catalog Download

Apr 20, 2021 | in vivo Studies

Antibodies for in vivo research since 1997 For over 20 years, scientists have trusted Bio X Cell as their go-to source...

InVivoSIM™ Biosimilar Antibodies from Bio X Cell

Mar 24, 2021 | in vivo Studies

What Are InVivoSIM™ Antibodies?
Bio X Cell InVivoSIM™ antibodies are research-grade biosimilar monoclonal antibodies. Each biosimilar antibody is produced using recombinant technology and incorporates the same variable region sequence as the original pharmaceutical drug.